PROM2 overexpression induces metastatic potential through epithelial‐to‐mesenchymal transition and ferroptosis resistance in human cancers

Justine Paris(Inserm), Guilhem Bousquet(Université Sorbonne Nouvelle)
Clinical and Translational Medicine
March 1, 2024
10.1002/ctm2.1632
Cited by 17

Related Papers

How to Make Anticancer Drugs Cross the Blood–Brain Barrier to Treat Brain Metastases
|International Journal of Molecular Sciences|2019|88
Pulsed-laser irradiation of multifunctional gold nanoshells to overcome trastuzumab resistance in HER2-overexpressing breast cancer
|Journal of Experimental & Clinical Cancer Research|2019|47
Metastatic clear-cell renal cell carcinoma: a frequent NOTCH1 mutation predictive of response to anti-NOTCH1 treatment
|Research Square|2022|0